.INVESTIGATION FEATURE.06 August 2024.
A sizable randomized controlled test with cisgender females highlights the challenges of adherence to a day-to-day dental preexposure prophylaxis regiment and also illustrates that twice-yearly treatment of lenacapavir can easily maintain reliable HIV protection degrees over 6 months.